Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D as adjuvant therapy in neonatal jaundice
NCT06650293Completed
- Start
- May 2022
- Primary completion
- Nov 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of vitamin d in jaundice (2 arms). Primary endpoint: Total Serum Bilirubin at 5 days. Started May 2022; status: completed.
02
Drugs
vitamin d
03
Conditions
jaundice
Beyond the preview
Go deeper on NCT06650293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06650293.